| Ponatinib |
Influence on protein activity |
Western Blot |
10.00 µM |
IMR-32 |
Homo sapiens |
|
|
|
| Ponatinib |
Influence on protein activity |
Western Blot |
10.00 µM |
NGP |
Homo sapiens |
|
|
|
| Ponatinib |
Influence on protein activity |
Western Blot |
10.00 µM |
NB-19 |
Homo sapiens |
|
|
|
| Ponatinib |
Influence on protein activity |
Western Blot |
10.00 µM |
SH-SY5Y |
Homo sapiens |
|
|
|
| Ponatinib |
Influence on protein activity |
Western Blot |
10.00 µM |
SK-N-AS |
Homo sapiens |
|
|
|
| Ponatinib |
Influence on protein activity |
Western Blot |
10.00 µM |
LA-N6 |
Homo sapiens |
|
|
|
| Ponatinib |
Influence on apoptotic protein activity in presence of Dox |
Western Blot |
1.00 µM |
NGP |
Homo sapiens |
|
|
|
| Ponatinib |
Influence on apoptotic protein activity in presence of Dox |
Western Blot |
1.00 µM |
SK-N-AS |
Homo sapiens |
|
|
|
| Ponatinib |
Influence on apoptotic protein activity in presence of Dox |
Western Blot |
1.00 µM |
LA-N6 |
Homo sapiens |
|
|
|
| Ponatinib |
Influence on protein activity in tumor tissue |
Western Blot |
15.00 mg/kg |
NB-19 (xenograft) |
Mus musculus |
NCr nude mice |
|
|
